ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

ASCO Teleconference Set For Nov. 12

October 31, 1986

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974

In Brief: Senate Committee Confirms Varmus; Albertini Directs Vermont Cancer Center

November 19, 1993